CD8A and neoplasm: While mice treated with a combination of IFNγ/α and anti-PD1 display a marginal reduction in tumor growth, it is not significant (Figures S4C and S4I) and no change in the levels of activated CD8+ T cells was observed in either the blood or the tumor (Figures S4J and S4K).